argenx SE (ADR)
General ticker "ARGX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $38.8B (TTM average)
argenx SE (ADR) follows the US Stock Market performance with the rate: 51.5%.
Estimated limits based on current volatility of 1.5%: low 792.44$, high 815.87$
Factors to consider:
- Total employees count: 73 as of 2017
Short-term ARGX quotes
Long-term ARGX plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $410.75MM | $1,226.32MM | $2,190.23MM |
| Operating Expenses | $1,131.09MM | $1,651.37MM | $2,211.89MM |
| Operating Income | $-720.34MM | $-425.05MM | $-21.65MM |
| Non-Operating Income | $-8.97MM | $120.55MM | $106.83MM |
| Interest Expense | $2.19MM | $0.90MM | $2.22MM |
| R&D Expense | $663.37MM | $859.49MM | $983.42MM |
| Income(Loss) | $-729.31MM | $-304.50MM | $85.18MM |
| Taxes | $-19.72MM | $-9.44MM | $-747.86MM |
| Profit(Loss)* | $-698.85MM | $-165.06MM | $833.04MM |
| Stockholders Equity | $2,813.70MM | $4,097.51MM | $5,498.28MM |
| Inventory | $228.35MM | $310.55MM | $407.23MM |
| Assets | $3,134.26MM | $4,542.46MM | $6,202.52MM |
| Operating Cash Flow | $-862.81MM | $-420.33MM | $-82.75MM |
| Capital expenditure | $103.82MM | $43.81MM | $68.30MM |
| Investing Cash Flow | $-461.18MM | $308.21MM | $-717.59MM |
| Financing Cash Flow | $843.76MM | $1,336.73MM | $279.76MM |
| Earnings Per Share** | $-12.85 | $-2.89 | $13.92 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.